Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Zomedica a Buy?

TheMotleyFool

0 0

Zomedica Pharmaceuticals (NYSEMKT: ZOM) has been one of the most intriguing (and best-performing) healthcare penny stocks in the past year. In fact, an investment of $10,000 in its shares last March would be worth well over $85,000 today. What's behind such astonishing gains?

As it turns out, the company has built a device that detects hormonal disorders in pets. If that doesn't sound exciting at all, well, investors think otherwise. Zomedica is now a billion-dollar company by market cap. Are shares on a path to take investors to the promised land? Or is the opportunity to make money on Zomedica stock largely over?

Image source: Getty Images.

Source Fool.com

Like: 0

ZOM

Share